We believe great partnerships create great possibilities and are inspired by our partners
As a global biopharmaceutical company, we leverage our agility, R&D capabilities and global footprint to develop valuable business partnerships that fuel tomorrow’s breakthrough discoveries across our three therapeutic areas: Oncology, Rare Disease and Neuroscience. External innovation is at the heart of our strategy. We believe in the expertise of our partners and value the opportunity to collaborate, bringing our skills, experience and global reach to accelerate innovation to bring new medicines to patients.
Exclusively sourcing our pipeline through external innovation, we have no internal competing pipeline as we recognize the best science is delivered in biotech and academic institutions. We are proud our team comprises talents attracted from Pharma, biotech and academia, to drive shared success through creative collaborations.
ONCOLOGY
Where we plan to expand
Solid tumors & hematology
- Precision medicine approaches
- BIC/FIC with strong science and meaningful differentiation
Smaller patient segments attractive for mid-sized companies
RARE DISEASE
Where we plan to expand
High unmet needs in underserved rare diseases
Drive liver & bone franchises; expand to new disease areas
Good fit for clinical development & go-to-market model
NEUROSCIENCE
Where we plan to expand
Rare neuroscience
Expand beyond neurotoxins in non-rare to adjacent areas
Strong innovation & scientific advances
Partnering with Ipsen
As a mid-size pharma, we leverage our agility, R&D capabilities and global footprint to develop valuable business partnerships that fuel tomorrow’s breakthrough discoveries across our three therapeutic areas: Oncology, Rare Disease and Neuroscience. External innovation is at the heart of our strategy. We believe in the expertise of our partners and value the opportunity to collaborate, bringing our skills, experience and global reach to accelerate innovation to bring new medicines to patients.
At Ipsen, we believe great partnerships create great possibilities. Data is just the beginning; we go beyond this to translate the clinical benefit into true patient impact. We focus on how one patient will have an enhanced experience because of each innovation and unite expertise to deliver this.
Pipeline
Our robust development pipeline, backed by our expertise and external-innovation strategy, supports patients’ health outcomes across Oncology, Rare Disease and Neuroscience.
Learn more
